Medical Treatments for Prostate Cancer

There are many different medical treatments for prostate cancer that involve the clinical care of a healthcare professional. These treatments include expectant therapy, surgery, radiation therapy, hormone therapy, and chemotherapy. Expectant therapy is to carefully observe and monitor the prostate cancer. Because prostate cancer cells often spread very slowly, many older men who have the disease may not need more extensive treatment. However, expectant therapy usually includes routine physician examinations, including digital rectal exams and PSA tests. The different types of surgery for prostate cancer are radical prostatectomy - an open-surgery procedure in which the entire prostate gland and surrounding tissue are removed. Transurethral resection of the prostate (TURP) - surgery to remove part of the prostate gland that surrounds the urethra. Cryosurgery - this procedure involves killing the cancer cells by freezing them with a small metal tool placed in the tumor. Side effects of prostate cancer surgery include incontinence and impotence. Incontinence is the inability to control urine and may result in dribbling of urine, especially immediately after surgery. Normal control usually returns within weeks or months after surgery. Impotence is the inability to achieve an erection. For a month, or so, after surgery, most men are not able to get an erection. Eventually, approximately 40 to 60 percent of men will be able to get an erection sufficient for sexual intercourse, but without ejaculation of semen, since removal of the prostate gland prevents that process.

Radiation therapy uses high energy rays to kill or shrink cancer cells, and to decrease their ability to divide. Radiation is often used to treat prostate cancer that is still confined to the prostate gland, or has spread only to nearby tissue. If the disease is advanced, radiation may be used to reduce the size of the tumor and to provide relief from symptoms. Possible side effects of radiation for prostate cancer may include diarrhea, with or without blood in the stool, and colitis, problems associated with urination, a degree of impotence (inability to get an erection), which may occur within two years of radiation therapy.

The goal of hormone therapy is to lower the level of male hormones in the body, particularly testosterone. Hormone therapy does not cure the cancer, and is often used to treat persons whose cancer has spread or recurred after treatment. Produced mainly in the testicles, testosterone causes prostate cancer cells to grow. Thus, reduced testosterone levels can make the prostate cancer shrink and become less active. Most studies show that hormone therapy works better if it is started early. Chemotherapy is the use of powerful, anti-cancer medications to kill cancer cells.. Hospitalization may be needed to monitor treatment and chemotherapy's side effects. Common side effects of chemotherapy include: nausea and vomiting, hair loss, anemia, reduced ability of blood to clot, mouth sores, increased likelihood of developing infections, fatigue. Most side effects disappear once treatment is stopped.

gene therapy and prostate cancer
Oncolytic Gene Therapy for Prostate Cancer
The overall purpose of this award has been to study the molecular pharmacology of replication restricted adenoviral vectors for prostate cancer gene therapy

Gene Technology in Australia
Gene therapy for prostate cancer. Prostate cancer is the most common cancer and the second leading cause of cancer death among men in western society.

The Johns Hopkins Gazette: October 25, 1999
Johns Hopkins cancer researchers report the successful use of human gene therapy to activate the human immune system against metastatic prostate cancer.

The Journal of Urology : Viral Mediated Gene Therapy for Prostate
Most preclinical investigations and phase 1 clinical gene therapy protocols for prostate cancer rely on direct intraprostatic injection for the delivery of

Prostate Cancer and Gene Therapy : Molecular Therapy
In some cases existing treatments for early prostate cancer fail, leading to advanced stage cancer that is merely managed and not cured. Gene therapy shows

Gene Therapy For Prostate Cancer from medicineworld.org
Gene Therapy For Prostate Cancer from medicineworld.org, your best source for health news and news blogs.

Research into treatments for prostate cancer
Gene therapy is in the very early research stages and we don't know if it will work yet. A UK trial looking at gene therapy for early stage prostate cancer

Optimizing prostate cancer suicide gene therapy using herpes
We sought to determine the optimal combination of tk variant and prodrug specifically for prostate cancer gene therapy, using in vitro and in vivo studies

IngentaConnect In situ gene therapy for prostate cancer
However, there are no curative therapies for metastatic prostate cancer. Gene therapy, especially those approaches with an immunomodulatory component,

Gene Therapy For Prostate Cancer at Henry Ford
Gene therapy for prostate cancer : The urologists at the Vattikuti Urology Institute specialize in the world's most advanced treatments of prostate cancer.

PSA Rising Prostate Cancer News, Info, Support
Tissue Scan May Improve Prostate Cancer Treatment April 2005. Pulsating ultrasound (HIFU) enhances gene therapy for tumors 26 Apr 2005

GENE THERAPY FOR PROSTATE CANCER: SENSITIZATION OF CELLS TO DNA
GENE THERAPY FOR PROSTATE CANCER: SENSITIZATION OF CELLS TO DNA DAMAGING DRUGS AND RADIATION. OTT REFERENCE: SOVI430501. Georgetown University is seeking a

Gene Therapy Study Takes Aim At Prostate Cancer
Researchers at Baylor College of Medicine (BCM) are hoping a new gene therapy that takes a gene called RTVP-1 directly into the prostate tumor will prove

Gene therapy of prostate cancer: current and future directions
Prostate cancer (PCA) is the second most common cause of death from malignancy in American men. Developing new approaches for gene therapy for PCA is

BBC News | HEALTH | Gene therapy for prostate cancer
The UK's first clinical trial of gene therapy for one of the most common cancers is being launched in Birmingham.

Gene Therapy Potent Against Advanced Prostate Cancer
"We did not know, however, that gene therapy and immunotherapy could be options for patients with locally advanced prostate cancer, a high-risk group to

The Current Status of Gene Therapy for Prostate Cancer
Methods: The authors review the most common genetic alterations in prostate cancer, the principles of gene therapy, and gene delivery including both viral

Gene Therapy Study Takes Aim At Prostate Cancer Prostate Cancer
The first phase of this prostate cancer treatment study is designed to test the safety of the treatment and determine the proper dosage of gene.


gene therapy and prostate cancer
cancer com prostate site
examination prostate self
advance cancer finding prostate research
enlarged prostate cancer